ERISPharmaceuticals
Eris Lifesciences Ltd — Quarterly Results & Earnings
₹1297.20
+2.05%
Profit Growth YoY31.23%Latest quarter
Sales Growth YoY6.91%Latest quarter
Sales CAGR 5Y21.92%5 year compound
Profit CAGR 5Y3.71%5 year compound
📋
Quarterly Performance
YoY Profit Growth+31.23%
🔥 Exceptional growth
YoY Sales Growth+6.91%
📈 Moderate growth
OPM 5Y Average
34.48%Operating profit margin
EPS Growth 5Y
3.65%Interest Coverage
3.76Higher = safer debt servicing
ROE
12.88%ROCE
12.22%💡
Growth Analysis
Eris Lifesciences Ltd reported YoY profit growth of 31.23% and revenue growth of 6.91% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 21.92% and profits at 3.71% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Eris Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.